Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals.

ABSTRACT:

Background

Buprenorphine is a highly effective medication for opioid use disorder that is underused by health care professionals (HCPs). Medications for opioid use disorder (MOUD) misinformation may be an important barrier to buprenorphine access, but most implementation strategies have aimed to reduce negative attitudes towards patients with opioid use disorder (OUD) rather than misinformation specific to buprenorphine use. In this study, we assessed the degree to which HCPs endorsed misinformation related to buprenorphine, and whether this is associated with willingness to provide care to patients with OUD.

Methods

In September-December of 2022, we surveyed HCPs practicing in Ohio (n = 409). Our primary outcomes included a previously validated 5-item measure of HCP willing

SUBMITTER: Franz B 

PROVIDER: S-EPMC10797921 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature